169 related articles for article (PubMed ID: 9662252)
1. Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity.
Mirjolet JF; Barberi-Heyob M; Merlin JL; Marchal S; Etienne MC; Milano G; Bey P
Br J Cancer; 1998 Jul; 78(1):62-8. PubMed ID: 9662252
[TBL] [Abstract][Full Text] [Related]
2. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
[TBL] [Abstract][Full Text] [Related]
3. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
[TBL] [Abstract][Full Text] [Related]
4. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil.
Beck A; Etienne MC; Chéradame S; Fischel JL; Formento P; Renée N; Milano G
Eur J Cancer; 1994; 30A(10):1517-22. PubMed ID: 7833111
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells.
Kirihara Y; Yamamoto W; Toge T; Nishiyama M
Int J Oncol; 1999 Mar; 14(3):551-6. PubMed ID: 10024690
[TBL] [Abstract][Full Text] [Related]
6. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.
Terashima M; Irinoda T; Fujiwara H; Nakaya T; Takagane A; Abe K; Yonezawa H; Oyama K; Inaba T; Saito K; Takechi T; Fukushima M
Anticancer Res; 2002; 22(2A):761-8. PubMed ID: 12014648
[TBL] [Abstract][Full Text] [Related]
7. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine.
Ma T; Zhu ZG; Ji YB; Zhang Y; Yu YY; Liu BY; Yin HR; Lin YZ
World J Gastroenterol; 2004 Jan; 10(2):172-6. PubMed ID: 14716816
[TBL] [Abstract][Full Text] [Related]
8. Intratumoural thymidylate synthase and dihydropyrimidine dehydrogenase activities are good predictors of 5-fluorouracil sensitivity in colorectal cancer.
Ishibiki Y; Kitajima M; Sakamoto K; Tomiki Y; Sakamoto S; Kamano T
J Int Med Res; 2003; 31(3):181-7. PubMed ID: 12870370
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
[TBL] [Abstract][Full Text] [Related]
10. Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa.
Miyamoto S; Ochiai A; Boku N; Ohtsu A; Tahara M; Yoshida S; Okabe H; Takechi T; Fukushima M
Int J Oncol; 2001 Apr; 18(4):705-13. PubMed ID: 11251164
[TBL] [Abstract][Full Text] [Related]
11. Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.
Bras-Gonçalves RA; Pocard M; Formento JL; Poirson-Bichat F; De Pinieux G; Pandrea I; Arvelo F; Ronco G; Villa P; Coquelle A; Milano G; Lesuffleur T; Dutrillaux B; Poupon MF
Gastroenterology; 2001 Mar; 120(4):874-88. PubMed ID: 11231942
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase and dihydropyrimidine dehydrogenase activities in non-small cell lung cancer tissues: relationship with in vitro sensitivity to 5-fluorouracil.
Higashiyama M; Kodama K; Yokouchi H; Takami K; Fukushima M; Minamigawa K; Takano T; Kobayashi H
Lung Cancer; 2001 Dec; 34(3):407-16. PubMed ID: 11714538
[TBL] [Abstract][Full Text] [Related]
13. Modulation of 5-fluorouracil by 5-ethyl-2'-deoxyuridine on cell lines expressing different dihydropyrimidine dehydrogenase activities.
Katona C; Tímár F; Jeney A; Fischel JL; Milano G; Pandi E; Kralovánszky J
Anticancer Drugs; 1999 Jul; 10(6):561-7. PubMed ID: 10885904
[TBL] [Abstract][Full Text] [Related]
14. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma.
Fujii R; Seshimo A; Kameoka S
Int J Clin Oncol; 2003 Apr; 8(2):72-8. PubMed ID: 12720098
[TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients.
Amatori F; Di Paolo A; Del Tacca M; Fontanini G; Vannozzi F; Boldrini L; Bocci G; Lastella M; Danesi R
Pharmacogenet Genomics; 2006 Nov; 16(11):809-16. PubMed ID: 17047489
[TBL] [Abstract][Full Text] [Related]
16. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test.
Kakimoto M; Uetake H; Osanai T; Shirota Y; Takagi Y; Takeshita E; Toriya Y; Danenberg K; Danenberg PV; Sugihara K
Cancer Lett; 2005 Jun; 223(1):103-11. PubMed ID: 15890242
[TBL] [Abstract][Full Text] [Related]
18. Significance of thymidylate synthase activity in renal cell carcinoma.
Mizutani Y; Wada H; Yoshida O; Fukushima M; Nonomura M; Nakao M; Miki T
Clin Cancer Res; 2003 Apr; 9(4):1453-60. PubMed ID: 12684419
[TBL] [Abstract][Full Text] [Related]
19. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer.
Fakhrejahani E; Miyamoto A; Tanigawa N
Cancer Chemother Pharmacol; 2007 Aug; 60(3):437-46. PubMed ID: 17377791
[TBL] [Abstract][Full Text] [Related]
20. Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines.
Ando T; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Sugito N; Mori R; Ogawa R; Katada T; Fujii Y
Dis Esophagus; 2008; 21(1):15-20. PubMed ID: 18197934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
